CIA
CL icon

Capital Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Capital Investment Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$947K Buy
11,114
+833
+8% +$74.2K 0.01% 352
2025
Q4 		$812K Buy
10,281
+959
+10% +$75.2K 0.01% 378
2025
Q3 		$745K Buy
9,322
+411
+5% +$35.1K 0.01% 395
2025
Q2 		$810K Sell
8,911
-304
-3% -$27.8K 0.01% 364
2025
Q1 		$863K Sell
9,215
-419
-4% -$37.5K 0.02% 338
2024
Q4 		$876K Buy
9,634
+238
+3% +$22.7K 0.02% 325
2024
Q3 		$975K Buy
9,396
+384
+4% +$39.1K 0.02% 302
2024
Q2 		$875K Buy
9,012
+31
+0.3% +$2.86K 0.02% 306
2024
Q1 		$809K Sell
8,981
-517
-5% -$43.8K 0.02% 317
2023
Q4 		$757K Sell
9,498
-14
-0.1% -$1.05K 0.02% 312
2023
Q3 		$676K Sell
9,512
-737
-7% -$55.1K 0.02% 308
2023
Q2 		$790K Sell
10,249
-86,966
-89% -$6.73M 0.02% 271
2023
Q1 		$7.31M Buy
97,215
+24,128
+33% +$1.79M 0.22% 95
2022
Q4 		$5.76M Buy
73,087
+64,162
+719% +$4.81M 0.17% 112
2022
Q3 		$627K Sell
8,925
-404
-4% -$31.7K 0.02% 306
2022
Q2 		$748K Buy
9,329
+54
+0.6% +$4.22K 0.02% 288
2022
Q1 		$703K Sell
9,275
-7
-0.1% -$554 0.02% 322
2021
Q4 		$792K Buy
9,282
+452
+5% +$35.3K 0.02% 314
2021
Q3 		$667K Sell
8,830
-198
-2% -$15.7K 0.02% 328
2021
Q2 		$734K Buy
9,028
+908
+11% +$74.2K 0.03% 315
2021
Q1 		$640K Sell
8,120
-995
-11% -$78K 0.02% 319
2020
Q4 		$779K Sell
9,115
-329
-3% -$27.2K 0.03% 278
2020
Q3 		$729K Sell
9,444
-1,054
-10% -$80.4K 0.03% 270
2020
Q2 		$769K Buy
10,498
+492
+5% +$34.9K 0.04% 253
2020
Q1 		$664K Buy
10,006
+1,352
+16% +$95.4K 0.04% 250
2019
Q4 		$596K Sell
8,654
-65
-0.7% -$4.43K 0.03% 297
2019
Q3 		$641K Sell
8,719
-200
-2% -$14.5K 0.03% 275
2019
Q2 		$639K Buy
8,919
+35
+0.4% +$2.48K 0.04% 273
2019
Q1 		$609K Sell
8,884
-30
-0.3% -$1.94K 0.04% 273
2018
Q4 		$531K Sell
8,914
-250
-3% -$15.6K 0.04% 275
2018
Q3 		$614K Buy
9,164
+146
+2% +$9.72K 0.04% 266
2018
Q2 		$584K Buy
9,018
+545
+6% +$35.6K 0.04% 271
2018
Q1 		$607K Buy
8,473
+403
+5% +$29K 0.04% 264
2017
Q4 		$609K Buy
8,070
+41
+0.5% +$2.99K 0.04% 265
2017
Q3 		$585K Sell
8,029
-289
-3% -$20.8K 0.04% 261
2017
Q2 		$617K Buy
8,318
+27
+0.3% +$2K 0.04% 250
2017
Q1 		$607K Hold
8,291
– – 0.05% 253
2016
Q4 		$543K Buy
8,291
+200
+2% +$13.7K 0.05% 259
2016
Q3 		$600K Sell
8,091
-21
-0.3% -$1.55K 0.05% 242
2016
Q2 		$594K Buy
8,112
+58
+0.7% +$4.13K 0.06% 238
2016
Q1 		$569K Sell
8,054
-428
-5% -$28.5K 0.06% 240
2015
Q4 		$565K Buy
8,482
+868
+11% +$57.7K 0.06% 234
2015
Q3 		$483K Sell
7,614
-68
-0.9% -$4.44K 0.05% 233
2015
Q2 		$502K Buy
7,682
+104
+1% +$7.05K 0.05% 236
2015
Q1 		$525K Sell
7,578
-100
-1% -$6.91K 0.06% 235
2014
Q4 		$531K Hold
7,678
– – 0.06% 236
2014
Q3 		$501K Hold
7,678
– – 0.06% 226
2014
Q2 		$523K Buy
7,678
+50
+0.7% +$3.35K 0.06% 224
2014
Q1 		$495K Hold
7,628
– – 0.06% 233
2013
Q4 		$497K Buy
+7,628
New +$488K 0.07% 225

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capital Investment Advisors's CL Position: Q1 2026 in Review

Capital Investment Advisors increased its Colgate-Palmolive (CL) stake by 8.1% in Q1 2026, buying an estimated $74.2K and bringing the position to 11,114 shares worth $947K. The position accounts for 0.01% of the portfolio, ranked #352.

Capital Investment Advisors first reported a position in CL in Q4 2013 and has held it in 50 quarters since. The position peaked at $7.31M in Q1 2023. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capital Investment Advisors held 11,114 shares of Colgate-Palmolive worth $947K as of Q1 2026.
  • Capital Investment Advisors bought 833 Colgate-Palmolive shares in Q1 2026, an estimated $74.2K.
  • Colgate-Palmolive made up 0.01% of Capital Investment Advisors's portfolio in Q1 2026, its #352 holding.
  • Capital Investment Advisors first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 50 quarters since.
  • Capital Investment Advisors's Colgate-Palmolive position peaked at $7.31M in Q1 2023.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.